{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T01:04:08Z","timestamp":1785200648987,"version":"3.55.0"},"reference-count":80,"publisher":"Oxford University Press (OUP)","issue":"14","license":[{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["MDA514964"],"award-info":[{"award-number":["MDA514964"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["9R42OD030543-02A"],"award-info":[{"award-number":["9R42OD030543-02A"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Duchenne muscular dystrophy (DMD) is a fatal X-linked genetic disorder affecting approximately 1 in 5000 male births worldwide. DMD is caused by mutations in the dystrophin gene. Dystrophin is essential for maintaining muscle cell membrane integrity and stability by linking the cytoskeleton to the extracellular matrix, which protects myofibers from contraction-induced damage. Loss of dystrophin leads to mechanically induced skeletal and cardiac muscle damage. Although the disease is not evident in DMD patients at birth, muscular dystrophy rapidly progresses and results in respiratory and cardiac muscle failure as early as the teenage years. Premature death in DMD patients is due to cardiac arrhythmias and left ventricular dysfunction. Currently, there is no effective treatment for DMD-related cardiac failure. Recently, we have shown that a Food and Drug Administration-approved small molecule, sunitinib, a multi-targeted tyrosine kinase inhibitor can mitigate skeletal muscle disease through an increase in myogenic capacity, cell membrane integrity, and improvement of skeletal muscle function via regulation of STAT3-related signaling pathway. Chronic activation of STAT3 has been shown to promote cardiac hypertrophy and failure. In this study, we examined the effects of long-term sunitinib treatment on cardiac pathology and function. Our results showed sunitinib treatment reduced STAT3 phosphorylation in the heart muscle of mdx mice, improved cardiac electrical function, increased cardiac output and stroke volume, decreased ventricular hypertrophy, reduced cardiomyocytes membrane damage, fibrotic tissue deposition and slightly decreased cardiac inflammation. Together, our studies support the idea that sunitinib could serve as a novel treatment to slow cardiomyopathy progression in DMD.<\/jats:p>\n               <jats:p>One Sentence Summary In this study, we determined if sunitinib, a Food and Drug Administration-approved drug, could reduce the pathology and improve cardiac function in an animal model for DMD.<\/jats:p>","DOI":"10.1093\/hmg\/ddac042","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T20:13:23Z","timestamp":1644437603000},"page":"2358-2369","source":"Crossref","is-referenced-by-count":9,"title":["Sunitinib inhibits STAT3 phosphorylation in cardiac muscle and prevents cardiomyopathy in the <i>mdx<\/i> mouse model of Duchenne muscular dystrophy"],"prefix":"10.1093","volume":"31","author":[{"given":"Ariany","family":"Oliveira-Santos","sequence":"first","affiliation":[{"name":"Department of Pharmacology, University of Nevada Reno, School of Medicine, Center for Molecular Medicine , Reno NV 89557 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisela","family":"Dagda","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Nevada Reno, School of Medicine, Center for Molecular Medicine , Reno NV 89557 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9228-5258","authenticated-orcid":false,"given":"Dean J","family":"Burkin","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Nevada Reno, School of Medicine, Center for Molecular Medicine , Reno NV 89557 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,2,14]]},"reference":[{"key":"2022072316292026600_ref1","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ejhg.2012.301","article-title":"Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK)","volume":"21","author":"Moat","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"key":"2022072316292026600_ref2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to Newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann. Neurol."},{"key":"2022072316292026600_ref3","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","article-title":"A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy","volume":"24","author":"Mah","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"2022072316292026600_ref4","first-page":"457","article-title":"Dystrophin: the protein product of the Duchene muscular dystrophy locus. 1987","volume":"24","author":"Hoffman","year":"1992","journal-title":"Biotechnol."},{"key":"2022072316292026600_ref5","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/339584a0","article-title":"The gene and its product","volume":"339","author":"Mandel","year":"1989","journal-title":"Nature"},{"key":"2022072316292026600_ref6","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/333466a0","article-title":"The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle","volume":"333","author":"Zubrzycka-Gaarn","year":"1988","journal-title":"Nature"},{"key":"2022072316292026600_ref7","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1073\/pnas.90.8.3710","article-title":"Dystrophin protects the sarcolemma from stresses developed during muscle contraction","volume":"90","author":"Petrof","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2022072316292026600_ref8","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1136\/bmj.317.7164.991","article-title":"Fortnightly review: the muscular dystrophies","volume":"317","author":"Emery","year":"1998","journal-title":"BMJ"},{"key":"2022072316292026600_ref9","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0960-8966(02)00140-2","article-title":"Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation","volume":"12","author":"Eagle","year":"2002","journal-title":"Neuromuscul. Disord."},{"key":"2022072316292026600_ref10","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.jacc.2016.02.081","article-title":"Dystrophin-deficient cardiomyopathy","volume":"67","author":"Kamdar","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"2022072316292026600_ref11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/NDT.S235166","article-title":"Left ventricular end-diastolic diameter and cardiac mortality in duchenne muscular dystrophy","volume":"16","author":"Segawa","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"2022072316292026600_ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.114.001338","article-title":"Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophy","volume":"4","author":"Tandon","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"2022072316292026600_ref13","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0002-8703(98)70057-2","article-title":"Sequential changes in cardiac structure and function in patients with Duchenne type muscular dystrophy: a two-dimensional echocardiographic study","volume":"135","author":"Sasaki","year":"1998","journal-title":"Am. Heart J."},{"key":"2022072316292026600_ref14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF02078410","article-title":"Cardiomyopathy of Duchenne muscular dystrophy","volume":"9","author":"D\u2019Orsogna","year":"1988","journal-title":"Pediatr. Cardiol."},{"key":"2022072316292026600_ref15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0167-5273(90)90082-G","article-title":"The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy","volume":"26","author":"Nigro","year":"1990","journal-title":"Int. J. Cardiol."},{"key":"2022072316292026600_ref16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10803-016-2961-8","article-title":"Cardiac management of the patient with Duchenne muscular dystrophy","volume":"47","author":"Gillentine","year":"2017","journal-title":"J. Autism Dev. Disord."},{"key":"2022072316292026600_ref17","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.amjcard.2008.08.064","article-title":"Re-examination of the electrocardiogram in boys with Duchenne muscular dystrophy and correlation with its dilated cardiomyopathy","volume":"103","author":"Thrush","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"2022072316292026600_ref18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0002-9343(67)90017-4","article-title":"The distinctive electrocardiogram of Duchenne\u2019s progressive muscular dystrophy: an electrocardiographic-pathologic correlative study","volume":"42","author":"Perloff","year":"1967","journal-title":"Am. J. Med."},{"key":"2022072316292026600_ref19","doi-asserted-by":"crossref","first-page":"5447","DOI":"10.1007\/s00018-021-03862-2","article-title":"The multifaceted view of heart problem in Duchenne muscular dystrophy","volume":"78","author":"Florczyk-Soluch","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"2022072316292026600_ref20","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/jpc.12868","article-title":"Duchenne muscular dystrophy","volume":"51","author":"Yiu","year":"2015","journal-title":"J. Paediatr. Child Health"},{"key":"2022072316292026600_ref21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nmd.2006.01.010","article-title":"Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade","volume":"16","author":"Biggar","year":"2006","journal-title":"Neuromuscul. Disord."},{"key":"2022072316292026600_ref22","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.braindev.2016.04.001","article-title":"Long-term outcomes of steroid therapy for Duchenne muscular dystrophy in Japan","volume":"38","author":"Goto","year":"2016","journal-title":"Brain Dev."},{"key":"2022072316292026600_ref23","first-page":"1","article-title":"Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy","volume":"2017","author":"Bell","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"2022072316292026600_ref24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.tcm.2017.12.006","article-title":"ACE inhibition to slow progression of myocardial fibrosis in muscular dystrophies","volume":"28","author":"Russo","year":"2018","journal-title":"Trends Cardiovasc. Med."},{"key":"2022072316292026600_ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms20174098","article-title":"Cardiac pathophysiology and the future of cardiac therapies in Duchenne muscular dystrophy","volume":"20","author":"Meyers","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"2022072316292026600_ref26","first-page":"1048","article-title":"Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing","volume-title":"RNA Biol.","author":"Hanson","year":"2021"},{"key":"2022072316292026600_ref27","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1093\/hmg\/ddz044","article-title":"Sunitinib promotes myogenic regeneration and mitigates disease progression in the mdx mouse model of Duchenne muscular dystrophy","volume":"28","author":"Fontelonga","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"2022072316292026600_ref28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00280-006-0376-5","article-title":"Sunitinib malate","volume":"60","author":"Izzedine","year":"2007","journal-title":"Cancer Chemother. Pharmacol."},{"key":"2022072316292026600_ref29","first-page":"327","article-title":"In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic\/pharmacodynamic relationship","volume":"9","author":"Mendel","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"2022072316292026600_ref30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/965631","article-title":"Understanding the process of fibrosis in duchenne muscular dystrophy","volume":"2014","author":"Kharraz","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"2022072316292026600_ref31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms20092164","article-title":"ERK: a key player in the pathophysiology of cardiac hypertrophy","volume":"20","author":"Gallo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"2022072316292026600_ref32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcvm.2019.00150","article-title":"An update on the multifaceted roles of STAT3 in the heart","volume":"6","author":"Harhous","year":"2019","journal-title":"Front. Cardiovasc. Med."},{"key":"2022072316292026600_ref33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cvr\/cvv210","article-title":"Cardiac protein kinases: the cardiomyocyte kinome and differential kinase expression in human failing hearts","volume":"108","author":"Fuller","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"2022072316292026600_ref34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00395-007-0658-z","article-title":"Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis","volume":"102","author":"Fischer","year":"2007","journal-title":"Basic Res. Cardiol."},{"key":"2022072316292026600_ref35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/01.RES.0000134921.50377.61","article-title":"Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury","volume":"95","author":"Hilfiker-Kleiner","year":"2004","journal-title":"Circ. Res."},{"key":"2022072316292026600_ref36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nm1199","article-title":"G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes","volume":"11","author":"Harada","year":"2005","journal-title":"Nat. Med."},{"key":"2022072316292026600_ref37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4161\/jkst.19776","article-title":"Differential STAT3 signaling in the heart","volume":"1","author":"Zgheib","year":"2012","journal-title":"Jak-Stat"},{"key":"2022072316292026600_ref38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cyto.2014.12.024","article-title":"The varying faces of IL-6: from cardiac protection to cardiac failure","volume":"74","author":"Fontes","year":"2015","journal-title":"Cytokine"},{"key":"2022072316292026600_ref39","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1074\/jbc.M111.246173","article-title":"Inhibition of signal transducer and activator of transcription 3 (STAT3) attenuates Interleukin-6 (IL-6)-induced collagen synthesis and resultant hypertrophy in rat heart","volume":"287","author":"Mir","year":"2012","journal-title":"J. Biol. Chem."},{"key":"2022072316292026600_ref40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/6699054","article-title":"Alleviation of inflammation and oxidative stress in pressure overload-induced cardiac remodeling and heart failure via IL-6\/STAT3 inhibition by raloxifene","volume":"2021","author":"Huo","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"2022072316292026600_ref41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1158\/1541-7786.MCR-09-0220","article-title":"Sunitinib induces apoptosis and growth arrest of medulloblastoma tumor cells by inhibiting STAT3 and AKT signaling pathways","volume":"8","author":"Yang","year":"2010","journal-title":"Mol. Cancer Res."},{"key":"2022072316292026600_ref42","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1158\/0008-5472.CAN-08-4323","article-title":"Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells","volume":"69","author":"Xin","year":"2009","journal-title":"Cancer Res."},{"key":"2022072316292026600_ref43","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.18632\/oncotarget.2812","article-title":"Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle","volume":"6","author":"Pretto","year":"2015","journal-title":"Oncotarget"},{"key":"2022072316292026600_ref44","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/mus.21716","article-title":"Timeline of cardiac dystrophy in 3-18-month-old mdx mice","volume":"42","author":"Van Erp","year":"2010","journal-title":"Muscle Nerve"},{"key":"2022072316292026600_ref45","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.nmd.2004.04.007","article-title":"Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings","volume":"14","author":"Quinlan","year":"2004","journal-title":"Neuromuscul. Disord."},{"key":"2022072316292026600_ref46","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1006\/bbrc.1999.1890","article-title":"Of mice and men: from early NMR studies of the heart to physiological genomics","volume":"266","author":"Radda","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2022072316292026600_ref47","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1006\/jmcc.1999.1018","article-title":"Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of duchenne muscular dystrophy","volume":"31","author":"Bia","year":"1999","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2022072316292026600_ref48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-10-33","article-title":"Myocardial inflammation in Duchenne muscular dystrophy as a precipitating factor for heart failure: a prospective study","volume":"10","author":"Mavrogeni","year":"2010","journal-title":"BMC Neurol."},{"key":"2022072316292026600_ref49","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1152\/ajpheart.00489.2007","article-title":"The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice","volume":"293","author":"Williams","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2022072316292026600_ref50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2613.2010.00750.x","article-title":"Increased connective tissue growth factor associated with cardiac fibrosis in the mdx mouse model of dystrophic cardiomyopathy","volume":"92","author":"Au","year":"2011","journal-title":"Int. J. Exp. Pathol."},{"key":"2022072316292026600_ref51","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0022-510X(86)90003-1","article-title":"The association of cardiac muscle necrosis and inflammation with the degenerative and persistent myopathy of MDX mice","volume":"72","author":"Bridges","year":"1986","journal-title":"J. Neurol. Sci."},{"key":"2022072316292026600_ref52","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/hmg\/11.3.263","article-title":"A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice","volume":"11","author":"Porter","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"2022072316292026600_ref53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1242\/dmm.043638","article-title":"Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress","volume":"13","author":"Grounds","year":"2020","journal-title":"Dis. Model. Mech."},{"key":"2022072316292026600_ref54","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1093\/hmg\/ddu113","article-title":"Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10","volume":"23","author":"Nitahara-Kasahara","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"2022072316292026600_ref55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aaa7322","article-title":"Immune-mediated pathology in Duchenne muscular dystrophy","volume":"7","author":"Rosenberg","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"2022072316292026600_ref56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-017-0660-3","article-title":"Role of inflammation in heart failure","volume":"19","author":"Shirazi","year":"2017","journal-title":"Curr. Atheroscler. Rep."},{"key":"2022072316292026600_ref57","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1253\/circj.CJ-18-0063","article-title":"Inflammatory mechanisms of cardiovascular remodeling","volume":"82","author":"Anzai","year":"2018","journal-title":"Circ. J."},{"key":"2022072316292026600_ref58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0028569","article-title":"In vivo MRI characterization of progressive cardiac dysfunction in the mdx mouse model of muscular dystrophy","volume":"7","author":"Stuckey","year":"2012","journal-title":"PLoS One"},{"key":"2022072316292026600_ref59","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/01.CIR.38.5.933","article-title":"The electrocardiogram in Duchenne progressive muscular dystrophy","volume":"38","author":"Slucka","year":"1968","journal-title":"Circulation"},{"key":"2022072316292026600_ref60","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1038\/mt.2011.154","article-title":"AAV-microdystrophin therapy improves cardiac performance in aged female mdx mice","volume":"19","author":"Bostick","year":"2011","journal-title":"Mol. Ther."},{"key":"2022072316292026600_ref61","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.amjcard.2014.04.038","article-title":"Left ventricular dysfunction in Duchenne muscular dystrophy and genotype","volume":"114","author":"Ashwath","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"2022072316292026600_ref62","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","article-title":"Hypertrophy of the heart: a new therapeutic target?","volume":"109","author":"Frey","year":"2004","journal-title":"Circulation"},{"key":"2022072316292026600_ref63","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/labinvest.3780092","article-title":"T-cell-dependent fibrosis in the mdx dystrophic mouse","volume":"80","author":"Morrison","year":"2000","journal-title":"Lab. Investig."},{"key":"2022072316292026600_ref64","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1177\/1074248416686189","article-title":"Dual therapy deflazacort\/doxycyclyne is better than deflazacort monotherapy to alleviate cardiomyopathy in dystrophin-deficient mdx mice","volume":"22","author":"Pereira","year":"2017","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"2022072316292026600_ref65","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/mus.23858","article-title":"Suramin attenuates dystrophin-deficient cardiomyopathy in the mdx mouse model of duchenne muscular dystrophy","volume":"48","author":"Moreira","year":"2013","journal-title":"Muscle Nerve"},{"key":"2022072316292026600_ref66","first-page":"1","article-title":"Systemic inflammation in duchenne muscular dystrophy: association with muscle function and nutritional status","volume":"6","author":"Del Roc\u00edo Cruz-Guzm\u00e1n","year":"2017","journal-title":"J. Nutr. Sci."},{"key":"2022072316292026600_ref67","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1093\/hmg\/ddv323","article-title":"Increased levels of interleukin-6 exacerbate the dystrophic phenotype in mdx mice","volume":"24","author":"Pelosi","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"2022072316292026600_ref68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/1987218","article-title":"Increased circulating levels of Interleukin-6 induce perturbation in redox-regulated signaling cascades in muscle of dystrophic mice","volume":"2017","author":"Pelosi","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"2022072316292026600_ref69","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.trsl.2018.09.004","article-title":"A long-term treatment with taurine prevents cardiac dysfunction in mdx mice","volume":"204","author":"Mele","year":"2019","journal-title":"Transl. Res."},{"key":"2022072316292026600_ref70","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ebiom.2015.02.014","article-title":"Functional and morphological improvement of dystrophic muscle by interleukin 6 receptor blockade","volume":"2","author":"Pelosi","year":"2015","journal-title":"EBioMedicine"},{"key":"2022072316292026600_ref71","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2018.01.048","article-title":"Topical sunitinib ointment alleviates psoriasis-like inflammation by inhibiting the proliferation and apoptosis of keratinocytes","volume":"824","author":"Kuang","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"2022072316292026600_ref72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph13110397","article-title":"Small-dose sunitinib modulates p53, Bcl-2, STAT3, and ERK1\/2 pathways and protects against adenine-induced nephrotoxicity","volume":"13","author":"Saleh","year":"2020","journal-title":"Pharmaceuticals"},{"key":"2022072316292026600_ref73","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1084\/jem.20051848","article-title":"The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells","volume":"203","author":"Sumimoto","year":"2006","journal-title":"J. Exp. Med."},{"key":"2022072316292026600_ref74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scisignal.2001180","article-title":"HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis","volume":"3","author":"Slinger","year":"2010","journal-title":"Sci. Signal."},{"key":"2022072316292026600_ref75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2017.00167","article-title":"The IL-6\/STAT3 signaling pathway is an early target of Manuka honey-induced suppression of human breast cancer cells","volume":"7","author":"Aryappalli","year":"2017","journal-title":"Front. Oncol."},{"key":"2022072316292026600_ref76","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1358\/dot.2006.42.6.985633","article-title":"Sunitinib: a newly approved small-molecule inhibitor of angiogenesis","volume":"42","author":"Cabebe","year":"2006","journal-title":"Drugs Today"},{"key":"2022072316292026600_ref77","first-page":"1871","article-title":"Cardiotoxicity associated with the tyrosine kinase inhibitor sunitinib","volume":"124","author":"Chen","year":"2012","journal-title":"Lancet"},{"key":"2022072316292026600_ref78","doi-asserted-by":"crossref","first-page":"135","DOI":"10.15616\/BSL.2015.21.3.135","article-title":"Validation of non-invasive method for electrocardiogram recording in mouse using lead II","volume":"21","author":"Kim","year":"2015","journal-title":"Biomed. Sci. Lett."},{"key":"2022072316292026600_ref79","doi-asserted-by":"crossref","first-page":"H733","DOI":"10.1152\/ajpheart.00339.2017","article-title":"Guidelines for measuring cardiac physiology in mice","volume":"314","author":"Lindsey","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2022072316292026600_ref80","first-page":"315","article-title":"Wheat germ agglutinin staining as a suitable method for detection and quantification of fibrosis in cardiac tissue after myocardial infarction","volume":"58","author":"Emde","year":"2014","journal-title":"Eur. J. Histochem."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/hmg\/advance-article-pdf\/doi\/10.1093\/hmg\/ddac042\/42960254\/ddac042.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/hmg\/article-pdf\/31\/14\/2358\/45050367\/ddac042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/hmg\/article-pdf\/31\/14\/2358\/45050367\/ddac042.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T16:31:05Z","timestamp":1658593865000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article\/31\/14\/2358\/6528270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":80,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2022,2,14]]},"published-print":{"date-parts":[[2022,7,21]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddac042","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7,15]]},"published":{"date-parts":[[2022,2,14]]}}}